Erythrasma

L12_ERYTHRASMA

erythrasma: a skin disease that causes brown, scaly skin patches. It is caused by the Gram-positive bacterium Corynebacterium minutissimum. It is prevalent among diabetics and the obese, and in warm climates; it is worsened by wearing occlusive clothing.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — L08.1 Hospital discharge: ICD-9 — 390 Cause of death: ICD-10 — L08.1 Cause of death: ICD-9 — 390 2 out of 7 registries used, show all original rules.	81
4. Check minimum number of events None	81
5. Include endpoints None	81
6. Filter based on genotype QC (FinnGen only)	77

Control definitions (FinnGen only)

Control exclude: L12_INFECT_SKIN

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: L08
Name in latin: Erythrasma

NAME	L12_ERYTHRASMA
CONTROL_EXCLUDE	L12_INFECT_SKIN
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	L081
HD_ICD_9	390
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	L081
COD_ICD_9	390
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Erythrasma based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	476	191	281
Only index persons	408	160	248
Unadjusted period prevalence (%)
Whole population	0.01	0.01	0.01
Only index persons	0.01	0.01	0.01
Median age at first event (years)
Whole population	50.66	50.13	50.99
Only index persons	47.94	47.52	48.22

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	77	26	51
Unadjusted period prevalence (%)	0.02	0.01	0.02
Median age at first event (years)	54.50	57.43	53.01

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

No data

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
80: Matched controls
800

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

L08.1

ICD-10 Finland

Erythrasma

+∞

94.5

L30.9

ICD-10 Finland

Dermatitis, unspecified

6.5

14.6

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

11.4

11.2

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

4.1

7.9

103

3900A

ICD-9 Finland

Rheumatic fever without mention of heart involvement[FEBRIS RHEUMATICA, MORBO CORDIS NON INDICATO]

+∞

7.4

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3007853) Bacteria identified in Skin by Aerobe culture

3.64

5.08

1.4

—

(3001604) Monocytes [#/volume] in Blood

294

2.87

4.93

7.1

5.9

0.62

0.57

e9/l

0.62

256

(3022096) Basophils/100 leukocytes in Blood

260

2.81

4.87

7.2

5.8

0.69

0.00

245

(3006504) Eosinophils/100 leukocytes in Blood

273

2.75

4.66

7.7

5.8

2.76

2.84

0.11

258

(40760892) CBC W Ordered Manual Differential panel - Blood

274

2.73

4.61

7.9

6.5

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

329

2.81

4.58

11.3

8.7

3.82

4.04

e9/l

0.36

290

(40768443) Skin Pathology biopsy report

5.69

4.53

1.1

—

(3019069) Monocytes/100 leukocytes in Blood

276

2.70

4.51

8.2

6.1

8.92

8.54

0.36

261

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

253

2.64

4.37

10.2

6.5

1.22

1.21

mmol/l

0.73

221

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

9.44

3.85

1.1

1.0

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

9.44

3.85

1.1

1.0

—

(3023368) Bacteria identified in Blood by Culture

131

2.60

3.68

4.0

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

198

2.36

3.40

5.4

2.4

—

(36304419) Bacteria [Presence] in Urine

144

2.45

3.35

4.8

2.1

—

(3037467) Urinalysis macro (dipstick) panel - Urine

382

2.27

2.94

5.9

3.8

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

100

2.49

2.91

1.0

1.3

1.88

17.37

u/ml

—

(3035637) Corticotropin [Mass/volume] in Plasma

8.78

2.79

1.0

1.3

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

120

2.29

2.60

1.4

1.3

1.97

1.29

u/ml

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

202

2.08

2.50

1.9

1.8

97.08

90.35

pmol/l

0.35

117

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

122

2.24

2.49

1.3

1.9

1.17

1.10

mg/l

0.06

107

(3018418) pH of Serum or Plasma

154

2.14

2.45

6.8

3.8

7.40

7.39

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

205

2.04

2.38

3.6

3.5

27.95

77.39

ng/l

1.13

140

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

103

2.26

2.31

1.1

1.4

41.60

45.48

iu/ml

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

2.57

2.30

7.6

5.2

102.93

103.75

mmol/l

0.27

(3007164) IgA [Mass/volume] in Serum or Plasma

111

2.21

2.28

1.6

1.4

3.52

2.46

g/l

0.93

(40768797) Stomach Pathology biopsy report

2.38

2.20

1.1

1.2

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

3.93

2.20

1.7

1.07

1.25

g/l

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

2.48

2.16

1.6

1.7

—

(3044290) Cell count panel - Cerebral spinal fluid

5.25

2.10

1.0

—

(3000330) Specific gravity of Urine by Test strip

3.17

1.99

5.8

3.9

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

2.21

1.98

4.6

2.0

0.94

0.71

e6/l

0.17

(3008037) Lactate [Moles/volume] in Venous blood

4.77

1.97

6.4

4.5

1.80

1.69

mmol/l

—

(3038515) Glucose [Moles/volume] in Venous blood

4.77

1.97

6.4

4.5

8.92

8.95

mmol/l

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

2.22

1.91

4.8

2.0

1.10

2.35

e6/l

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

111

2.07

1.91

1.5

1.7

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

3.73

1.87

1.8

0.21

0.27

g/l

—

(40758558) Short blood count panel - Blood

144

1.95

1.85

5.1

6.5

—

(3004588) Protein electrophoresis panel - Serum or Plasma

2.85

1.78

1.6

2.9

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

2.25

1.77

4.6

2.3

2.49

2.33

g/l

0.41

(3017143) Hepatitis C virus Ab [Presence] in Serum

2.10

1.77

1.6

1.8

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

2.31

1.77

1.5

1.7

—

(3026008) Bacteria identified in Urine by Culture

122

1.98

1.77

4.6

2.8

—

(3025159) Blasts/100 leukocytes in Blood

2.71

1.74

6.0

3.9

0.20

0.14

—

(3005719) IgG [Mass/volume] in Serum or Plasma

2.44

1.72

1.7

1.8

12.70

10.14

g/l

0.53

(3000991) Gas panel - Venous blood

2.64

1.72

7.4

4.5

—

(3027945) Reticulocytes/100 erythrocytes in Blood

2.34

1.71

1.3

2.8

1.70

1.90

0.26

(1761482) Bacteria [#/volume] in Urine by Culture

3.33

1.69

5.8

5.5

—

(3020682) Albumin/Creatinine [Ratio] in Urine

165

1.85

1.69

6.5

3.7

16.72

10.28

mg/mmol

0.21

110

(3022217) INR in Platelet poor plasma by Coagulation assay

262

1.77

1.68

19.2

13.0

1.07

1.23

inr

0.86

(3002385) Erythrocyte distribution width [Ratio]

523

1.96

1.66

23.7

14.5

14.44

14.88

0.38

510

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2.05

1.60

1.6

1.9

—

(3022948) Iron [Moles/volume] in Serum or Plasma

2.08

1.57

4.5

2.3

13.26

15.70

umol/l

0.48

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

2.74

1.55

9.1

5.1

24.70

24.73

mmol/l

—

(3044640) Blood type and Crossmatch panel - Blood

169

1.80

1.55

2.1

2.2

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

3.48

1.54

1.0

1.1

596.00

491.73

mg/l

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

3.00

1.53

1.3

1.1

—

(3012516) Albumin [Mass/volume] in Urine

153

1.81

1.52

4.3

3.3

139.16

77.25

mg/l

0.23

105

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

2.64

1.49

2.6

2.2

43.29

40.16

u/l

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

2.73

1.39

1.2

1.0

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

3.06

1.38

2.4

2.1

48.80

132.35

ug/min

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

2.50

1.33

4.8

126.13

129.71

g/l

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

126

1.78

1.30

1.6

2.0

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

2.41

1.21

3.3

3.2

0.67

0.78

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

246

1.58

1.14

3.0

2.3

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

2.00

1.14

1.4

1.7

—

(3045414) Leukocytes [Presence] in Urine

2.35

1.05

1.0

1.3

—

(3021589) Normoblasts [#/volume] in Blood

260

1.54

1.04

13.8

8.6

0.00

e9/l

-0.00

204

(3035350) Ketones [Presence] in Urine by Test strip

289

1.52

1.02

5.2

3.2

0.00

estimate

—

(3025941) Bacteria identified in Stool by Culture

2.03

1.00

1.3

—

(3021601) Nitrite [Presence] in Urine by Test strip

292

1.50

0.96

7.0

4.5

0.00

estimate

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

2.32

0.96

11.2

3.9

48.53

49.92

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

2.32

0.96

3.3

3.1

1.52

1.60

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

2.15

0.91

8.5

4.7

24.28

24.13

mmol/l

—

(3009261) Glucose [Presence] in Urine by Test strip

297

1.46

0.86

5.2

3.2

0.00

estimate

—

(40768804) Tissue Pathology biopsy report

232

1.47

0.84

1.9

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

116

1.59

0.83

1.2

1.7

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

0.00

0.80

0.0

1.6

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

419

1.44

0.79

4.5

3.5

14.58

14.52

pmol/l

0.05

388

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1.92

0.76

1.7

—

(3019832) Treponema pallidum Ab [Presence] in Serum

1.68

0.75

1.9

1.8

—

(3041096) Erythrocytes [Presence] in Urine by Automated

172

1.47

0.75

5.3

2.9

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

2.06

0.74

2.4

1.2

—

(3020961) Endomysium IgA Ab [Titer] in Serum

2.06

0.74

1.2

1.1

—

(36660697) Celiac disease serology panel - Serum

1.77

0.72

1.3

1.2

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1.91

0.69

8.2

7.9

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

1.91

0.69

1.2

1.4

—

(3044889) 12 lead EKG panel

405

1.39

0.69

4.0

3.6

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1.69

0.69

3.0

4.3

—

(40761536) Microorganisms panel - Urine sediment

1.69

0.69

7.6

3.3

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1.84

0.67

2.2

1.8

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1.77

0.65

1.0

1.3

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1.71

0.62

3.2

4.4

4.06

4.92

pmol/l

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

0.00

0.61

0.0

4.0

—

85.00

—

(3042936) Bacteria identified in Isolate by Culture

1.57

0.61

1.9

1.7

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

125

1.46

0.60

1.9

2.1

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1.53

0.59

1.8

1.6

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1.62

0.58

2.2

2.0

—

(3000494) Fungus identified in Specimen by Culture

1.52

0.55

1.4

1.3

—

(3022145) Colonoscopy Study observation

1.48

0.54

1.6

1.3

—

(3017732) Neutrophils [#/volume] in Blood

1.54

0.49

5.0

2.6

3.64

10.32

e9/l

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1.50

0.48

1.6

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

233

1.31

0.48

5.1

3.3

—

(3016502) Oxygen saturation in Arterial blood

1.50

0.45

7.1

6.3

94.75

95.91

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.41

0.0

1.7

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

0.00

0.41

0.0

4.5

—

193.47

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1.36

0.39

1.1

1.4

—

(3003694) ABO and Rh group [Type] in Blood

163

1.30

0.39

1.4

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

222

1.25

0.36

3.5

3.9

25.06

20.78

0.54

106

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

532

1.25

0.34

5.8

4.2

2.10

1.85

mu/l

0.81

493

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

606

1.28

0.32

20.8

12.3

20.10

22.26

mg/l

0.27

464

(3019550) Sodium [Moles/volume] in Serum or Plasma

618

1.28

0.30

22.6

13.2

139.82

139.74

mmol/l

0.09

602

(3013512) EKG study

169

1.24

0.29

6.7

3.8

—

(1761868) Lipid panel - Serum or Plasma

241

1.18

0.23

5.6

2.6

—

(3019060) Gas panel - Arterial blood

1.23

0.22

3.6

5.2

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

0.00

0.21

0.0

1.1

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

0.00

0.21

0.0

3.0

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

0.00

0.21

0.0

1.4

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

0.00

0.21

0.0

3.8

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

0.00

0.21

0.0

1.5

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.2

—

64.22

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

0.00

0.21

0.0

4.2

—

2.46

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.2

—

173.96

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

0.00

0.21

0.0

1.3

—

(3019225) pH of Specimen

1.24

0.20

4.2

4.5

—

(4094501) Cardiovascular stress test using bicycle ergometer

0.00

0.20

0.0

1.4

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1.14

0.18

10.4

6.6

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

662

1.18

0.14

24.2

13.7

87.76

81.27

umol/l

0.51

662

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

581

1.13

0.13

17.8

10.5

81.09

84.41

ml/min/173m2

0.40

469

(3011397) Hemoglobin [Presence] in Urine by Test strip

125

1.15

0.11

4.6

3.1

—

(4035726) Immunohistochemistry procedure

1.04

0.08

1.3

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1.12

0.08

1.1

1.4

—

(3002256) Pathology report gross observation

1.08

0.08

1.6

1.2

—

(3029937) Albumin [Presence] in Urine by Test strip

151

1.07

0.03

5.0

3.4

0.00

estimate

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

422

1.04

0.02

2.6

3.4

—

(3035941) MCH [Entitic mass]

694

1.07

0.01

31.2

17.6

30.22

30.38

0.31

685

(40761511) CBC panel - Blood by Automated count

655

1.04

0.00

20.3

11.5

—

(3000963) Hemoglobin [Mass/volume] in Blood

695

1.06

0.00

31.3

17.8

137.93

140.25

g/l

0.65

687

(3024731) MCV [Entitic volume]

695

1.06

0.00

31.3

17.6

90.41

90.75

0.26

686

(3026361) Erythrocytes [#/volume] in Blood

695

1.06

0.00

31.3

17.6

4.60

4.64

e12/l

0.23

676

(3009542) Hematocrit [Volume Fraction] of Blood

695

1.06

0.00

31.1

17.5

41.15

41.34

0.12

659

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

591

0.99

0.00

6.0

4.3

6.29

5.90

mmol/l

1.08

548

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

159

1.01

0.00

3.1

2.7

0.46

0.71

ug/l

1.53

112

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.3

—

(3035320) C reactive protein [Mass/volume] in Body fluid

0.00

0.0

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.3

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

0.00

0.0

2.8

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.9

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

0.00

0.0

2.0

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

0.00

0.0

1.0

—

(40768441) Liver Pathology biopsy report

0.00

0.0

1.0

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

0.00

0.0

1.9

—

5.30

—

(3011985) Renin [Units/volume] in Plasma

0.00

0.0

1.1

—

13.50

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

0.00

0.0

2.3

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

0.00

0.0

5.1

—

23.43

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

0.00

0.0

1.4

—

(3029075) Extractable nuclear Ab panel - Serum

0.00

0.0

1.0

—

(40765096) Chromosome analysis panel by Banding

0.00

0.0

1.0

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

0.00

0.0

1.4

—

8.06

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

0.00

0.0

2.3

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

0.00

0.0

1.0

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

0.00

0.0

1.4

—

12.78

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

0.00

0.0

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

0.00

0.0

2.0

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.3

—

(3025130) Human papilloma virus identified in Specimen

0.00

0.0

1.7

—

(3020650) Glucose [Presence] in Urine

0.00

0.0

1.6

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

0.00

0.0

1.0

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

0.00

0.0

1.2

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

0.00

0.0

1.2

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

0.00

0.0

1.1

—

221.57

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

0.00

0.0

2.6

—

68.60

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

0.00

0.0

1.0

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

0.00

0.0

1.1

—

(3000093) Morphology [Interpretation] in Blood Narrative

0.00

0.0

1.4

—

(40768793) Breast Pathology biopsy report

0.00

0.0

1.3

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

2.5

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

0.00

-0.00

0.0

1.2

—

1.61

—

(3016038) Potassium [Moles/volume] in Urine

0.00

-0.00

0.0

1.0

—

29.83

—

(3000492) Spirometry study

0.87

-0.00

1.3

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

0.92

-0.00

1.7

2.2

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

0.97

-0.00

2.1

2.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

2.5

—

(3035933) Granulocytes/100 leukocytes in Blood

0.00

-0.00

0.0

1.0

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

0.00

-0.00

0.0

1.0

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

0.00

-0.00

0.0

2.3

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

2.5

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

0.00

-0.00

0.0

1.3

—

Mortality – FinRegistry

↥

Association

Association between endpoint L12_ERYTHRASMA and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have L12_ERYTHRASMA.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: L12_ERYTHRASMA – Erythrasma

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Erythrasma

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints